Your session is about to expire
← Back to Search
4% EDTA for Catheter-Associated Infections (CLiCK Trial)
CLiCK Trial Summary
This trial will test whether a new type of catheter locking solution can help reduce complications in patients with central venous access devices.
- Catheter-Associated Infections
- Catheter Blockage
- Catheters
- Catheter Dysfunction
- Central Venous Catheter Thrombosis
- Central Line Bloodstream Infection
- Catheter Complications
- Catheter-related Bloodstream Infection
CLiCK Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CLiCK Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Are there still vacancies for participants in this experiment?
"Affirmative. The clinical trial's data on clinicaltrials.gov states that recruitment is still in progress, with the initial posting having taken place March 22nd 2022 and the last update occurring July 5th 2021. A total of 1690 participants need to be recruited from across five sites."
How many research locations are enacting this experiment?
"The ongoing medical study is located in 5 diverse locations, including Nanaimo Regional General Hospital, Royal Columbian Hospital and St. Boniface Hospital; with two additional sites also offering the intervention."
What is the cap for enrollment in this research project?
"Correct. Information available on clinicaltrials.gov affirms that this trial, which was initiated on March 22nd 2022, is actively enrolling participants. A total of 1690 individuals need to be recruited from 5 different sites."
What objectives are being pursued in this research endeavor?
"This clinical trial aims to measure the Primary Composite Outcome of CVAD Complications Modifiable by Lock Procedures within a 16 months timeframe, starting from randomization. The secondary outcomes are Incidence rate of catheter-associated venous thrombosis, Incidence of catheter obstruction requiring alteplase use., and Incidence rate of catheter colonization."
Share this study with friends
Copy Link
Messenger